Navigation Links
NARSAD announces $12.6 million for new generation of brain and behavior research
Date:1/6/2011

(GREAT NECK, N.Y. JANUARY 6, 2011) NARSAD: The Brain and Behavior Research Fund awards $12.6 million in new research grants, strengthening its investment in the most promising ideas to lead to breakthroughs in understanding and treating mental illness. Two-hundred fourteen brilliant researchers from leading research institutions on six continents have been selected from more than 1,000 applicants to receive Young Investigator grant awards to support their innovative research. Since 1987 NARSAD has been leading the development of the mental health research field and has awarded more than $274 million in 4,046 grants to 3,319 scientists around the world.

Young Investigators represent a new generation of researchers who will pioneer breakthroughs in mental health research. Young Investigator grants are catalysts for additional funding, providing researchers with "proof of concept" for their work. On average, NARSAD Young Investigators have used their grants to leverage an additional 19 times their original grant amount and some have gone on to receive much more than that after proving initial hypotheses with the first NARSAD grant support. Receiving up to $60,000 over two years, Young Investigators pursue brain and behavior research related to schizophrenia, depression, bipolar disorder, autism ADHD, and anxiety disorders, such as OCD and PTSD.

The 124-member NARSAD Scientific Council, a volunteer group of preeminent mental health researchers leads the rigorous and competitive process of identifying the most promising ideas for NARSAD to fund in grant awards each year. The Young Investigator selection process was led by Scientific Council member Dr. Herbert Meltzer of Vanderbilt University, a founding member of the council.

"The Young Investigator program is a hallmark of NARSAD grants, funding the research of young scientists on the quest to find breakthroughs in the field of mental health," said Benita Shobe, NARSAD president and CEO. "This body of research represents the cutting-edge of brain and behavior research. Young Investigators are selected for their innovation and potential to improve the lives of people living with mental illness through enhanced treatments and therapies and a better understanding of the causes of mental illness."


'/>"/>

Contact: Barbara Wheeler
bwheeler@narsad.org
516-829-0091
NARSAD, The Mental Health Research Association
Source:Eurekalert

Related medicine news :

1. Ming T. Tsuang recognized with NARSAD outstanding achievement award for schizophrenia research
2. Wiley-Blackwell announces 102 additional products available through Research4Life
3. IDSA announces first guidelines for treatment of MRSA infections
4. Elsevier Foundation announces 2010 grants for libraries in developing countries
5. ASH announces 2010 merit award winners
6. HFES announces Release of Reviews of Human Factors and Ergonomics, Volume 6
7. AAPS announces 2010 Fellows
8. Elsevier announces new partnership with CCS to publish the Canadian Journal of Cardiology
9. Genomic Systems announces moratorium on studying and treating terminal cancer has ended
10. MJFF announces over $10 million in funding for clinical and pre-clinical PD research
11. ESC announces new initiatives for workplace heart health programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... Dr. Angela Cotey, a noted general ... accepting new pediatric patients, with or without a referral. Dr. Cotey knows that ... orthodontic outcome and experience. When patients receive early treatment, they may achieve straight teeth ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... buildings (MOBs) and other outpatient facilities, and who are the most active developers? ... those questions, Revista and Healthcare Real Estate Insights (HREI) found that outpatient medical ...
(Date:3/29/2017)... ... , ... Curio Wellness , a premium medical cannabis brand and trusted ... management team with prominent executives from both inside and outside the cannabis industry. ... Ted Dumbauld , who has more than twenty years of business leadership and investment ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an important webinar ... at 1:00 PM ET. A recording of the webinar will also be made available ... Home health and hospice companies are still popular targets for healthcare investors. This highly ...
(Date:3/29/2017)... ... 2017 , ... Immunotherapy has emerged as one of the most promising options ... be the next revolution in our fight against this complex disease. One of the ... checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single analyte ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Calif. , March 29, 2017  Experts ... recognized remote monitoring devices like  Soberlink Systems  as ... The consensus paper, published in early 2017, concluded ... and valuable in managing patient recovery." ... the Journal of Addiction Medicine, detail a range ...
(Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, ... for GSP 301, an investigational fixed-dose combination of ... mcg) administered twice-daily as a nasal spray being ... These results are from a recently completed Phase ... GSP 301 combination therapy versus mometasone, olopatadine or ...
(Date:3/29/2017)... , Mar. 29, 2017 Research and ... Market 2017-2021" report to their offering. ... The global lifestyle drugs market to ... The report, Global Lifestyle Drugs Market 2017-2021, has been ... experts. The report covers the market landscape and its growth prospects ...
Breaking Medicine Technology: